Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial

about

Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin

P2860

Q34634865-ED99F3DF-1662-45C6-8C89-434458543CEA

P2860

Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial

Item

http://www.wikidata.org/entity/Q35566784

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Intracoronary dipyridamole red ...... a prospective randomised trial

@ast

Intracoronary dipyridamole red ...... a prospective randomised trial

@en

type

Item

label

Intracoronary dipyridamole red ...... a prospective randomised trial

@ast

Intracoronary dipyridamole red ...... a prospective randomised trial

@en

prefLabel

Intracoronary dipyridamole red ...... a prospective randomised trial

@ast

Intracoronary dipyridamole red ...... a prospective randomised trial

@en

P1476

Intracoronary dipyridamole red ...... a prospective randomised trial

@en

P2093

Heidland UE

http://www.w3.org/2001/XMLSchema#string

Heintzen MP

http://www.w3.org/2001/XMLSchema#string

Kelm M

http://www.w3.org/2001/XMLSchema#string

Klimek WJ

http://www.w3.org/2001/XMLSchema#string

Leschke M

http://www.w3.org/2001/XMLSchema#string

Michel CJ

http://www.w3.org/2001/XMLSchema#string

Schwartzkopff B

http://www.w3.org/2001/XMLSchema#string

Strauer BE

http://www.w3.org/2001/XMLSchema#string

Vester EG

http://www.w3.org/2001/XMLSchema#string

P2860

Percutaneous transluminal coronary angioplasty for unstable angina.

Cardiovascular purinoceptors.

Platelet inhibitor agents in cardiovascular disease: an update.

Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.

Dipyridamole.

Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.

Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty.

High incidence of acute coronary occlusions complicating percutaneous transluminal coronary angioplasty for angina pectoris.

Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.

P304

551-556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HEART.83.5.551

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2000-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12547515

http://www.w3.org/2001/XMLSchema#string

P698

10768906

http://www.w3.org/2001/XMLSchema#string

P932

1760836

http://www.w3.org/2001/XMLSchema#string

Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial

about

P2860

P2860

Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932